Exam Prep Ch18 Hiv And Aids The Fourth Decade - Answer Key + Test Bank | Controversies in Public Health 1e by Carney by Jan Kirk Carney. DOCX document preview.

Exam Prep Ch18 Hiv And Aids The Fourth Decade

Chapter 18: HIV and AIDS: The Fourth Decade

Multiple Choice

1. Challenges in achieving a “cure” of HIV infection are in part because:

A. Various cells and body tissues may harbor “reservoirs” of HIV-1 infection

B. Funding for bone marrow transplants has declined dramatically

C. There is a misperception that HIV cannot be cured

D. Genetic markers, indicative of cure, may be inaccurate

Page 320

2. The first reports of what is now known as HIV infection began when five healthy young men were reported with which infection?

A. Tuberculosis

B. Influenza

C. Pneumocystis carinii

D. C. difficile

Page 321

3. What change was made by the CDC to enable better tracking of public health progress against HIV and AIDS?

A. Regular national AIDS reports

B. Tracking HIV infection

C. Local surveys of treatment needs

D. News reports of cures

Page 321

4. Estimated new HIV infections are not evenly distributed, and are most common in which population?

A. Black female IDUs

B. White heterosexual women

©2016 Jones & Bartlett Learning, LLC 1

C. Black MSM
D. White MSM

Page 323

5. CDC estimates there are how many new HIV infections each year in the U.S.?

A. 10,000

B. 25,000

C. 50,000

D. 100,000

Page 322

6. Highest rates of HIV infection were seen in which of the following states?

A. Alaska

B. Utah

C. New York

D. Maine

Page 324

7. The use of two different antiretroviral medications taken daily to prevent HIV infection in individuals not HIV infected is called:

A. Pre-exposure prophylaxis (PrEP)

B. Community prevention

C. Risk behavior modification

D. Infection control and prevention

Page 328

8. Reports of the apparent cure of an HIV-infected patient after stem-cell transplantation for acute leukemia called this individual:

A. Transiently improved

B. Berlin patient

C. Genetically cured

D. Anecdotal

Page 330

9. An innovative approach to simulate genetic resistance to HIV infection involved an enzyme called:

A. CCR5

B. HIV synthetase

C. Zinc-finger nuclease

D. Infection mutase

Page 331

10. The most important risk factor for HIV transmission is:

A. Viral load

B. Community resources

C. Consistent behavioral approaches

D. Access to health care

Page 332

True or False

11. An innovation reported in 2014 involved gene editing, in an attempt to give patients acquired genetic resistance to HIV infection.

Page 320

12. The history of the AIDS pandemic has included controversies in the areas of prevention, treatment, research, and funding.

Page 321

13. HIV and AIDS is now in its third decade in the United States.

Page 321

14. Serologic testing algorithm for recent HIV seroconversion (STARHS) can help tell whether an infection occurred more than one year prior.

Page 322

15. Getting an HIV test is associated with engaging in less-risky behaviors.

Page 322

16. About 20% of new HIV infections in 2010 were in women.

Page 323

17. Discovery and widespread use of highly active antiretroviral therapy led to reductions in HIV/AIDS deaths in developed countries.

Page 326

18. Globally, use of antiretroviral therapy has not led to significant reductions in HIV/AIDS deaths in low- and middle-income countries.

Page 316

19. It is estimated that about 50% of individuals with HIV infection in the U.S. are getting appropriate treatment.

Page 328

20. An HIV Prevention Trials Network study in 9 countries shows that early antiretroviral therapy decreased both HIV transmission and HIV-related clinical conditions.

Page 328

21. Use of PrEP along with established prevention methods have been demonstrated to result in declines in HIV infections in MSM.

Page 329

22. If a person is homozygous for the 32-bp deletion in the CCR5 allele, the individual is genetically resistant to HIV infection.

Page 331

23. Public health experts believe an effective vaccine used with other effective prevention methods will accelerate progress against HIV.

Page 332

24. The number of new HIV infections in the U.S. has declined dramatically in the past five years.

Page 333

25. Local HIV prevention and treatment initiatives have demonstrated success in different U.S. locations.

Page 333

Multiple Answer

26. Some of the data systems used to help monitor progress against HIV includes:

A. Serologic testing algorithm for recent HIV seroconversion (STARHS)

B. Medical Monitoring Project (MMP)

C. National HIV Behavioral Surveillance system (NHBS)

D. National Health Interview Survey (NHIS)

Page 322

27. Which of the following prevention strategies were emphasized at the 2014 International AIDS Conference?

A. Guidelines for HIV testing

B. Condoms

C. Using ART in HIV-infected mothers

D. PrEP

Page 330

28. Which populations are especially challenging to reach with HIV prevention strategies?

A. Low-income countries

B. Injection-drug users

C. Older Americans

D. Pregnant women

Page 332

29. Goals of CDC’s “High-Impact Prevention” strategy include:

A. Measurable goals

B. Improving access to care for people with HIV

C. Reducing health disparities related to HIV infection

D. Establishing geographic priorities

Page 332

30. Challenges in the fourth decade of HIV include:

A. Controversy over PrEP

B. Reaching all populations with prevention and treatment

C. Lack of an effective vaccine

D. Sustained global commitment

Page 334

Document Information

Document Type:
DOCX
Chapter Number:
18
Created Date:
Aug 21, 2025
Chapter Name:
Chapter 18 Hiv And Aids The Fourth Decade
Author:
Jan Kirk Carney

Connected Book

Answer Key + Test Bank | Controversies in Public Health 1e by Carney

By Jan Kirk Carney

Test Bank General
View Product →

$24.99

100% satisfaction guarantee

Buy Full Test Bank

Benefits

Immediately available after payment
Answers are available after payment
ZIP file includes all related files
Files are in Word format (DOCX)
Check the description to see the contents of each ZIP file
We do not share your information with any third party